Drawing on her expertise, Dr. Zinaï will be supporting Tollys in its early clinical developments.
- Tollys appoints Amina Zinaï, MD, as head of clinical development
- Tollys welcomes Dr. Jean-Pierre Armand as member of its scientific advisory board
- Tollys appoints Philippe Goupit as chairman of the board
- Tollys extends its executive management team with appointment of Bettina Werle as CSO
- Tollys receives over €1.5 million deep tech financing from Bpifrance